...
首页> 外文期刊>American Journal of Cancer Research >Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma
【24h】

Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma

机译:口腔鳞状细胞癌旁源13 HOX基因的失控。

获取原文
           

摘要

Many oncogenic drivers related to the pathogenesis of OSCC have identified, but the discovery of new molecular markers for early detection of this cancer, remains one the main goals of clinical research. HOX genes regulate normal embryonic development, cell differentiation and other critical processes in eukaryotic cell life. Several studies have demonstrated that the deregulation of HOX genes play a significant role in cancer development and progression. In this study, we built a prognostic TMA with 119 OSCC samples, representative of deep and superficial part of the tumour, to investigate, the paralogous 13 HOX proteins expression, correlating them with clinicpathological parameters, outcomes and therapy information. Our results show an aberrant expression of HOX A13 and HOX D13 in OSCC pathogenesis and tumour progression. HOX A13 overexpression is related to an OSCC better prognosis (P=0.029) and better therapy response in patients treated with both radiotherapy and chemotherapy (P=0.015). HOX D13 overexpression is inversely related to an overall survival (P=0.004). These data highlight the potential prognostic role of HOX paralogous group 13 genes in OSCC.
机译:已经发现了许多与OSCC发病机理有关的致癌驱动因素,但是发现用于早期检测该癌症的新分子标记仍然是临床研究的主要目标之一。 HOX基因调节真核细胞生命中的正常胚胎发育,细胞分化和其他关键过程。多项研究表明,HOX基因的失控在癌症的发展和进程中起着重要作用。在这项研究中,我们用119例OSCC样品(代表肿瘤的深部和浅表部分)建立了预后性TMA,以研究旁源13 HOX蛋白的表达,并将其与临床病理参数,结果和治疗信息相关联。我们的结果显示,HOX A13和HOX D13在OSCC发病机制和肿瘤进展中异常表达。 HOX A13的过表达与放化疗联合化疗的患者的OSCC预后更好(P = 0.029)和更好的治疗反应有关(P = 0.015)。 HOX D13过表达与总生存率成反比(P = 0.004)。这些数据突出了HOCC同源13组基因在OSCC中的潜在预后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号